Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05067647 · ClinicalTrials.gov registry record · NA

A Study of the ENSEAL® X1 Curved Jaw Tissue Sealer and Generator G11 in Thoracic, Urologic, and Ear, Nose, and Throat (ENT) Procedures

A NA study, sponsored by Ethicon Endo-Surgery.

Completed
Registry status
NA
Development phase
94
Enrollment target

NCT05067647 is a NA study that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 94 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05067647, a NA study, has completed, sponsored by Ethicon Endo-Surgery.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target

Study Summary

The purpose of this study is to demonstrate the acceptable performance and safety of the ENSEAL X1 curved jaw tissue sealer and Ethicon endo-surgery generator G11 (GEN11) devices when used per the instructions for use (IFU).

Interventions

  • DEVICE ENSEAL X1 Curved Jaw Tissue Sealer

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2021-11-29
Est. Completion 2022-11-30
Phase NA

Sponsor

Ethicon Endo-Surgery

39 total trials

What the Registry Record Tells You About NCT05067647

The ClinicalTrials.gov registry entry for NCT05067647 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ENSEAL X1 Curved Jaw Tissue Sealer is the first listed.

NCT05067647 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05067647 about?

NCT05067647 is a clinical study titled "A Study of the ENSEAL® X1 Curved Jaw Tissue Sealer and Generator G11 in Thoracic, Urologic, and Ear, Nose, and Throat (ENT) Procedures". The purpose of this study is to demonstrate the acceptable performance and safety of the ENSEAL X1 curved jaw tissue sealer and Ethicon endo-surgery generator G11 (GEN11) devices when used per the instructions for use (IFU).

What is the current status of trial NCT05067647?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2021-11-29. Estimated completion is 2022-11-30.

What interventions are being tested in trial NCT05067647?

The interventions under investigation include: ENSEAL X1 Curved Jaw Tissue Sealer (DEVICE).

Who is sponsoring clinical trial NCT05067647?

This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.